Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of British Columbia

$918,000.00

Longitudinal non-invasive optical biopsy of low risk skin neoplasms in dermatology clinics to monitor efficacy and response to treatment

FY 2025-26

Summary
Patients are routinely referred to dermatology clinics for assessment of various skin lesions. Although, some of these skin lesions may be high-risk skin cancers, which require surgical treatment, a large proportion of patients may have low-risk skin lesions, including actinic keratoses (precancerous), Bowens disease (squamous cell carcinoma in situ) or basal cell carcinoma. These low-risk neoplasms may be treated with non-surgical or less invasive treatments. Typically, to diagnose these skin neoplasms, a surgical biopsy is taken and the skin is studied through a microscope (known as histology). Surgical biopsies are invasive and have certain risks, such as pain, infection, bleeding and scarring, which makes them impractical to perform repeatedly. We will use non-invasive optical imaging methods as an alternative to surgical biopsy. This will help us obtain microscopic views and other information from the skin, and help us evaluate a variety of skin conditions. We will study 400 patients being treated for low risk skin neoplasms in dermatology clinics and serially scan them for the presence of abnormal cells at regular intervals following treatment. Through this, we will evaluate how effective commonly used treatments are for clearing low risk skin neoplasms and compare optical biopsy findings to histology to confirm our results. This research will offer a novel way of monitoring skin conditions following treatment, without undesired effects to the patient. This will improve care by increasing our understanding of skin neoplasms, efficacy of less invasive and non-surgical treatments, and by guiding treatment to improve cure rates. This will provide crucial insights on how best to use less-invasive treatments and help improve patient experiences.
Program
Project Grant
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
565740
Name
Ahad Tashmeeta
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Longitudinal non-invasive optical biopsy of low risk skin neoplasms in dermatology clinics to monitor efficacy and response to treatment
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$918,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Dermatology; Skin
Abstract
Patients are routinely referred to dermatology clinics for assessment of various skin lesions. Although, some of these skin lesions may be high-risk skin cancers, which require surgical treatment, a large proportion of patients may have low-risk skin lesions, including actinic keratoses (precancerous), Bowens disease (squamous cell carcinoma in situ) or basal cell carcinoma. These low-risk neoplasms may be treated with non-surgical or less invasive treatments. Typically, to diagnose these skin neoplasms, a surgical biopsy is taken and the skin is studied through a microscope (known as histology). Surgical biopsies are invasive and have certain risks, such as pain, infection, bleeding and scarring, which makes them impractical to perform repeatedly. We will use non-invasive optical imaging methods as an alternative to surgical biopsy. This will help us obtain microscopic views and other information from the skin, and help us evaluate a variety of skin conditions. We will study 400 patients being treated for low risk skin neoplasms in dermatology clinics and serially scan them for the presence of abnormal cells at regular intervals following treatment. Through this, we will evaluate how effective commonly used treatments are for clearing low risk skin neoplasms and compare optical biopsy findings to histology to confirm our results. This research will offer a novel way of monitoring skin conditions following treatment, without undesired effects to the patient. This will improve care by increasing our understanding of skin neoplasms, efficacy of less invasive and non-surgical treatments, and by guiding treatment to improve cure rates. This will provide crucial insights on how best to use less-invasive treatments and help improve patient experiences.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Ahad, Tashmeeta; Kalia, Sunil; Lui, Harvey; Zeng, Haishan
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $918,000~ $0~
University of British Columbia - $918,000 Grant (2025… | Canada Spends